TY - JOUR
T1 - Alcohol and tobacco consumption as risk factors for alzheimer’sdisease
T2 - A collaborative re-analysisof case-control studies
AU - A Hofman For The Eurodem Risk Factors Research Group
AU - Graves, A. B.
AU - Van Duijn, C. M.
AU - Chandra, V.
AU - Fratiglioni, L.
AU - Heyman, A.
AU - Jorm, A. F.
AU - Kokmen, E.
AU - Kondo, K.
AU - Mortimer, J. A.
AU - Rocca, W. A.
AU - Shalat, S. L.
AU - Soininen, H.
PY - 1991
Y1 - 1991
N2 - A meta-analysis, involving the secondary analysis of original data from 11 case-control studies of Alzheimer’s disease, is presented for alcohol consumption and cigarette smoking. Five studies were included in the meta-analysis of alcoholconsumption. Alcohol consumption was computed in terms of average weekly intake, measured in ounces of ’purealcohol’. This variable was categorized into tertiles to represent low, medium and high intake. Analyses showed noexcess estimated risk of Alzheimer’s disease for any level of alcohol intake. Smoking was analysed in three differentmanners: (1) lifetime prevalence of smoking (ever/never)—this included eight studies; (2) amount smoked (less thanor equal to one pack per day versus more than one pack per day)—this included seven studies; and (3) pack-years—including four studies. A statistically significant inverse association between smoking and Alzheimer’s disease wasobserved at all levels of analysis, with a trend towards decreasing risk with increasing consumption (p= 0.0003). A propensity towards a stronger inverse relation was observed among patients with a positive family hisfory of dementia, but the difference between this group and the group with no such history was not statistically significant. Although the observed disturbance in nicotinic receptor function in Alzheimer’s disease may provide an explanation for thesefindings, possible biases related to the selection or survival of study subjects cannot be fully ruled out at this time. Prospective, community-based studies of incident cases of Alzheimer’s disease are needed to document in detail the smoking history, age of onset of disease and survival of patients and co gnitively intact people by smoking status.
AB - A meta-analysis, involving the secondary analysis of original data from 11 case-control studies of Alzheimer’s disease, is presented for alcohol consumption and cigarette smoking. Five studies were included in the meta-analysis of alcoholconsumption. Alcohol consumption was computed in terms of average weekly intake, measured in ounces of ’purealcohol’. This variable was categorized into tertiles to represent low, medium and high intake. Analyses showed noexcess estimated risk of Alzheimer’s disease for any level of alcohol intake. Smoking was analysed in three differentmanners: (1) lifetime prevalence of smoking (ever/never)—this included eight studies; (2) amount smoked (less thanor equal to one pack per day versus more than one pack per day)—this included seven studies; and (3) pack-years—including four studies. A statistically significant inverse association between smoking and Alzheimer’s disease wasobserved at all levels of analysis, with a trend towards decreasing risk with increasing consumption (p= 0.0003). A propensity towards a stronger inverse relation was observed among patients with a positive family hisfory of dementia, but the difference between this group and the group with no such history was not statistically significant. Although the observed disturbance in nicotinic receptor function in Alzheimer’s disease may provide an explanation for thesefindings, possible biases related to the selection or survival of study subjects cannot be fully ruled out at this time. Prospective, community-based studies of incident cases of Alzheimer’s disease are needed to document in detail the smoking history, age of onset of disease and survival of patients and co gnitively intact people by smoking status.
UR - http://www.scopus.com/inward/record.url?scp=0025740733&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025740733&partnerID=8YFLogxK
U2 - 10.1093/ije/20.Supplement_2.S48
DO - 10.1093/ije/20.Supplement_2.S48
M3 - Article
C2 - 1833354
AN - SCOPUS:0025740733
SN - 0300-5771
VL - 20
SP - S48-S57
JO - International journal of epidemiology
JF - International journal of epidemiology
ER -